Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1373/week)
    • Manufacturing(678/week)
    • Energy(536/week)
    • Technology(1315/week)
    • Other Manufacturing(482/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Myelodysplastic syndrome

Jun 15, 2020
Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product
Jun 12, 2020
EHA25Virtual: Promising Treatment Results with Imetelstat, a Novel Telomerase Inhibitor, in Patients with Lower Risk Myelodysplastic Syndromes
Jun 10, 2020
Ryvu Therapeutics Reports First Quarter 2020 Financial Results
May 14, 2020
Ryvu Therapeutics Announces Availability of Abstracts Regarding Phase 1/2 Study of SEL120 and SEL24/MEN1703 Accepted for Presentation at 25th EHA Congress
May 14, 2020
Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS)
Mar 28, 2020
Ryvu Therapeutics Receives Orphan Drug Designation From FDA for SEL120 to Treat Acute Myeloid Leukemia
Feb 21, 2020
Actinium Presents Positive Findings from Mid-Point Analysis of Pivotal SIERRA Trial of Iomab-B at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT)
Feb 03, 2020
CTI BioPharma Establishes Accelerated Approval Pathway for Pacritinib in Treating Myelofibrosis Patients With Severe Thrombocytopenia
Dec 18, 2019
Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug
Nov 19, 2019
Biosight Announces Data to be Presented at ASH 2019 Annual Meeting
Nov 06, 2019
Actinium Announces Interim Results from Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML Accepted for Presentation at ASH 2019
Sep 06, 2019
Selvita Announces First Patient Dosed in Phase 1b Study of CDK8 Inhibitor SEL120 in the Treatment of Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Jul 31, 2019
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
Jul 25, 2019
Selvita Appoints Setareh Shamsili, M.D., Ph.D., as Chief Medical Officer
Jun 17, 2019
Data Presented At 24 Congress of the European Hematology Association Demonstrates Clinical Safety, Early Efficacy of Imago BioSciences' IMG-7289 in Myelofibrosis Patients
Jun 12, 2019
Curis Highlights Publication in Nature Cell Biology Identifying Cancer-Causing Form of IRAK4 in Patients with AML and MDS
Jun 04, 2019
Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO Annual Meeting
May 16, 2019
Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress
May 16, 2019
Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting
Apr 25, 2019
Health Union Survey Reveals Half of Blood Cancer Cases Detected from Symptoms, Other Half Incidental
  •  
  • Page 1
  • ››

Latest News

May 16, 2025

International Seaways and V. Partner to Launch Female Cadet Program

May 16, 2025

HAFNIA LIMITED: Correction of Fleet Value Presentation for the First Quarter 2025

May 16, 2025

BW LPG Limited – Results of Annual General Meeting 2025

May 16, 2025

Faraday Future Announces Annual Stockholders’ Day on May 31; Top 10 Attending Stockholders to Receive...

May 16, 2025

Lithium Royalty Corp. Announces Final Results of Substantial Issuer Bid

May 16, 2025

Fonon Technologies DefenseTech: Pioneering the Fight Against Saltwater Corrosion

May 16, 2025

Babcock selects Exail to deliver flight simulators for the French Armed Forces under the Mentor 2 program

May 16, 2025

Terma Unveils ‘SCANTER Sphera’: A State-of-the-Art 3D Counter-Drone Radar

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
21
May
United KingdomLondon, UK
Space Operations Summit, 21 - 22 May 2025, London, UK
Space Operations Summit | 21 - 22 May, 2025 | London, UK Space Operations Summit 2025 is the only conference to look at...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia